Taloporfin (Laserphyrin)
Revision as of 01:55, 11 June 2023 by Warner-admin (talk | contribs) (Text replacement - ": new" to ": New")
Photosensitizer
Diseases for which it is used
History of changes in PMDA indication
- 2013-09-20: New additional indication and a new dosage for the treatment of primary malignant brain tumor (only for the case where surgical excision of tumor is performed).
- 2015-05-26: New additional indication for the treatment of recurrent esophageal cancer associated with local persistence after chemoradiotherapy or radiotherapy.